We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+17.22%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$397M
AUM Growth
+$54.6M
Cap. Flow
-$1.75M
Cap. Flow %
-0.44%
Top 10 Hldgs %
71.23%
Holding
50
New
2
Increased
12
Reduced
27
Closed
–

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$259K
2
DUK icon
Duke Energy
DUK
+$189K
3
TGT icon
Target
TGT
+$177K
4
NOW icon
ServiceNow
NOW
+$131K
5
NVDA icon
NVIDIA
NVDA
+$127K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$825K
2
ABBV icon
AbbVie
ABBV
+$543K
3
GILD icon
Gilead Sciences
GILD
+$409K
4
AZN icon
AstraZeneca
AZN
+$354K
5
ISRG icon
Intuitive Surgical
ISRG
+$127K

Sector Composition

Rank Sector Weight
1 Technology 42.33%
2 Consumer Discretionary 28.14%
3 Healthcare 17.65%
4 Communication Services 10.14%
5 Utilities 0.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
26
AstraZeneca
AZN
$263B
$1.56M 0.39%
11,589
-2,721
-19% -$354K
BMY icon
27
Bristol-Myers Squibb
BMY
$128B
$1.42M 0.36%
27,692
-5
-0% -$262
ABBV icon
28
AbbVie
ABBV
$454B
$1.42M 0.36%
9,157
-3,727
-29% -$543K
COST icon
29
Costco
COST
$422B
$1.12M 0.28%
1,697
-34
-2% -$20.2K
ABT icon
30
Abbott
ABT
$182B
$785K 0.2%
7,134
-182
-2% -$18.2K
MRK icon
31
Merck
MRK
$323B
$733K 0.18%
6,723
-243
-3% -$25.2K
JNJ icon
32
Johnson & Johnson
JNJ
$641B
$721K 0.18%
4,601
-100
-2% -$15.3K
BA icon
33
Boeing
BA
$167B
$683K 0.17%
2,619
-40
-2% -$8.55K
PAYX icon
34
Paychex
PAYX
$41.1B
$644K 0.16%
5,405
– –
JPM icon
35
JPMorgan Chase
JPM
$947B
$600K 0.15%
3,526
-40
-1% -$6.06K
NUE icon
36
Nucor
NUE
$56.4B
$559K 0.14%
3,210
-10
-0.3% -$1.59K
DE icon
37
Deere & Co
DE
$169B
$532K 0.13%
1,330
-10
-0.7% -$3.77K
URGN icon
38
UroGen Pharma
URGN
$2.02B
$521K 0.13%
34,701
– –
CAT icon
39
Caterpillar
CAT
$402B
$418K 0.11%
1,414
-8
-0.6% -$2.08K
BCRX icon
40
BioCryst Pharmaceuticals
BCRX
$2.43B
$339K 0.09%
56,600
– –
V icon
41
Visa
V
$689B
$271K 0.07%
1,042
-78
-7% -$19.2K
EOLS icon
42
Evolus
EOLS
$407M
$264K 0.07%
25,070
– –
ORCL icon
43
Oracle
ORCL
$345B
$252K 0.06%
2,389
– –
IDXX icon
44
Idexx Laboratories
IDXX
$43.9B
$234K 0.06%
422
-38
-8% -$17.8K
PFE icon
45
Pfizer
PFE
$141B
$223K 0.06%
7,755
-555
-7% -$16.8K
TGT icon
46
Target
TGT
$63.7B
$207K 0.05%
+1,450
New +$177K
DUK icon
47
Duke Energy
DUK
$100B
$202K 0.05%
+2,080
New +$189K
PLSE icon
48
Pulse Biosciences
PLSE
$2.27B
$126K 0.03%
10,325
– –
SMMT icon
49
Summit Therapeutics
SMMT
$10.5B
$62.8K 0.02%
24,059
– –
CMRX
50
DELISTED
Chimerix, Inc.
CMRX
$10.2K ﹤0.01%
10,609
– –
1
2

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Bender Robert & Associates held 50 positions worth $397M, up 16% from $342M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 4%. Bender Robert & Associates opened 2 new positions and made no exits, leaving the 50-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q4 2023 buy was Duke Energy: 2,080 shares worth $202K.
  • Bender Robert & Associates added most to Palo Alto Networks in Q4 2023, an estimated $259K increase.
  • Bender Robert & Associates's biggest Q4 2023 reduction was Apple, cutting an estimated $825K.
  • Bender Robert & Associates's ten largest holdings make up 71% of its $397M portfolio in Q4 2023.
  • Bender Robert & Associates opened 2 new positions and closed 0 in Q4 2023.
  • Bender Robert & Associates's portfolio value rose 16% quarter-over-quarter to $397M.

Based on Bender Robert & Associates's 13F filing for Q4 2023, filed 31 Jan 2024.